Masood Shammas

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth
    Jagannath Pal
    Department of Adult Oncology, Harvard Dana Farber Cancer Institute, Boston, MA, USA
    Cancer Genomics Proteomics 9:55-66. 2012
  2. ncbi Telomeres, lifestyle, cancer, and aging
    Masood A Shammas
    Harvard Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Curr Opin Clin Nutr Metab Care 14:28-34. 2011
  3. ncbi Purification of diseased cells from Barrett's esophagus and related lesions by laser capture microdissection
    Masood A Shammas
    Department of Medical Oncology, Harvard Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
    Methods Mol Biol 755:181-7. 2011
  4. ncbi Identification of genes modulated in multiple myeloma using genetically identical twin samples
    Nikhil C Munshi
    Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston MA 02115, USA
    Blood 103:1799-806. 2004
  5. ncbi Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cell
    Jooeun Bae
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    J Immunol 178:7730-7. 2007
  6. ncbi Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma
    Pierfrancesco Tassone
    Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute and VA Boston Healthcare System, Harvard Medical School, Boston, Massachusetts 02115, USA
    Clin Cancer Res 11:4251-8. 2005

Research Grants

  1. Telomerase And Homologous Recombination As Targets In Barrett's Adenocarcinoma
    Masood A Shammas; Fiscal Year: 2010

Detail Information

Publications6

  1. ncbi Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth
    Jagannath Pal
    Department of Adult Oncology, Harvard Dana Farber Cancer Institute, Boston, MA, USA
    Cancer Genomics Proteomics 9:55-66. 2012
    ..Simultaneous suppression of PI3K and RAD51, especially in cells with lower AKT expression, can significantly reduce their proliferative potential...
  2. ncbi Telomeres, lifestyle, cancer, and aging
    Masood A Shammas
    Harvard Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Curr Opin Clin Nutr Metab Care 14:28-34. 2011
    ..The purpose of this review was to highlight the importance of telomeres in human health and aging and to summarize possible lifestyle factors that may affect health and longevity by altering the rate of telomere shortening...
  3. ncbi Purification of diseased cells from Barrett's esophagus and related lesions by laser capture microdissection
    Masood A Shammas
    Department of Medical Oncology, Harvard Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
    Methods Mol Biol 755:181-7. 2011
    ..This chapter, therefore, emphasizes the importance of laser capture microdissection and provides the method to purify Barrett's esophagus related cells, using this technique...
  4. ncbi Identification of genes modulated in multiple myeloma using genetically identical twin samples
    Nikhil C Munshi
    Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston MA 02115, USA
    Blood 103:1799-806. 2004
    ..By identifying genes uniquely altered in MM cells compared with normal PCs in an identical genotypic background, the current study provides the framework to identify novel therapeutic targets...
  5. ncbi Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cell
    Jooeun Bae
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    J Immunol 178:7730-7. 2007
    ....
  6. ncbi Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma
    Pierfrancesco Tassone
    Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute and VA Boston Healthcare System, Harvard Medical School, Boston, Massachusetts 02115, USA
    Clin Cancer Res 11:4251-8. 2005
    ....

Research Grants2

  1. Telomerase And Homologous Recombination As Targets In Barrett's Adenocarcinoma
    Masood A Shammas; Fiscal Year: 2010
    ..We will also identify the agents which would re-activate shortening of chromosome ends in these cells and inhibit the growth of this cancer. ..